Physician profile
Robert C Rivers
NPI 1225163769
$973.37
in general payments reported to CMS, 2019-2025
10 companies · $42.82 in 2025
The $42.82 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.39 · 2022: $15.19 · 2023: $15.74 · 2024: $872 · 2025: $42.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $812 · Food and Beverage: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $812.36 |
| Food and Beverage | $118.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $812.36 | 2024 | |
| Tela Bio, INC. | $27.12 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $22.12 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Vertex Pharmaceuticals Incorporated | $19.25 | 2024 | |
| Organogenesis INC. | $18.50 | 2024 | |
| Hologic Sales and Service, LLC | $15.74 | 2023 | Localizer, Trident Specimen Radiography System, Biozorb |
| Smith+Nephew, INC. | $15.70 | 2025 | Collagenase Santyl |
| Mission Pharmacal Company | $15.19 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $14.19 | 2021 | |
| Axonics, INC. | $13.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rivers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.